Physician duties · PharmD · Florida
Signing for a Pharmacist in Florida: what the physician takes on
The agreement is mandatory for the clinician, which makes its duties mandatory for you. Florida calls the instrument a Written Collaborative Pharmacy Practice Agreement.
Two narrow, physician-gated pathways rather than general independent prescribing: §465.1865 (chronic conditions — arthritis, asthma, COPD, type 2 diabetes, HIV/AIDS, obesity, others by Board rule) and §465.1895 (2020 'test and treat' — flu, strep, lice, ringworm, athlete's foot, minor uncomplicated infections). Both exclude controlled substances entirely.
Independent practice requires: Certified under §465.1865 (collaborative pharmacy practice, chronic conditions) or §465.1895 (2020 'test and treat,' minor conditions), each requiring an executed written agreement/protocol with a supervising Ch. 458/459 physician.
What you take on as the physician
The rules the physician relationship has to follow. Each fact comes from the statute or board rule listed under sources.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
As needed
§465.1895's written protocol must specify a 'physician review process and schedule' — frequency is determined by the individual protocol, not fixed by statute. §465.1865's collaborative practice agreement has no analogous review-schedule mandate found.
Prescriptive authority
Separate prescribing terms required · no controlled-substance authority
Both §465.1865 and §465.1895 explicitly exclude controlled substances (referencing §893.03/21 U.S.C. §812) from the pharmacist's delegated authority — no schedule of controlled substance may be initiated or prescribed under either pathway.
Written agreement
Required
True for both pathways — an executed written agreement (§465.1865) or protocol (§465.1895) is mandatory to invoke either one; there is no branch where a pharmacist prescribes under this framework without one.
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — Non-pharmacists may own a Florida pharmacy (§465.015(4)(b), §465.022) — no ownership restriction by license. Clinical control instead runs through a designated 'prescription department manager' (community pharmacies, §465.018) or 'consultant pharmacist' (institutional pharmacies, §465.019) — Florida's statutory terms for the role commonly called 'pharmacist in charge' (PIC) in industry usage.
Materially more permissive than the physician/APRN framework above, same pattern as other states' pharmacist entries in this dataset.
Legal sources for these rules (4)
- Fla. Stat. § 465.1865 — Collaborative Pharmacy Practice for Chronic Health Conditions
- Fla. Stat. § 465.1895 — Pharmacist testing and treatment of minor, nonchronic conditions
- Fla. Stat. §§ 465.015, 465.018, 465.019, 465.022, 465.0196 — Pharmacy ownership/permits
- Florida Board of Pharmacy — Collaborative Practice Certification
What physicians charge for this role
Typical monthly compensation in Florida
$500 – $600
Estimate for one Pharmacist. Standard-tier state.
About Florida's rules
Florida's 2020 autonomous-practice law (§464.0123, ≥3,000 supervised hours + coursework) creates a real independence pathway for NP and CNM — but excludes PMHNP, CRNA, and CNS entirely; CRNA autonomy bills have died three sessions running (2024-2026). Florida has no corporate-practice-of-medicine doctrine (secondary-source consensus) — entity ownership instead turns on the Health Care Clinic Act's §400.9905 exemption mechanics. Supervision ratio/chart-review/meeting-cadence are largely uncodified; PA's 10-supervisee cap is the exception.
Other clinicians in Florida: see the state overview.